Antiemetics¶
Hesketh, P. J., Kris, M. G., Basch, E., Bohlke, K., Barbour, S. Y., Clark-Snow, R. A., Danso, M. A., et al. (2017). Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology, 35(28), 3240-3261.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Intervention-Coupled Harm
- The compensator move layers a separate-channel intervention that targets the coupled harm without dismantling the benefit channel — anti-emetics for chemotherapy nausea, accessibility overrides for security friction.
This sourceEstablishes anti-emetics as a separate-channel compensator targeting chemotherapy-induced nausea without altering the cytotoxic mechanism.
- The compensator move layers a separate-channel intervention that targets the coupled harm without dismantling the benefit channel — anti-emetics for chemotherapy nausea, accessibility overrides for security friction.
Verification¶
This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.
Registry ID ref:cbb3f21ce398 · see in the full table